Two other significant factors are mentioned repeatedly as well: The massive cost of covering GLP-1 drugs (which it appears many insurers are dropping coverage of after only a couple of years), and the sunsetting of MA's 2-year ConnectorCare expansion program
The critical distinction: injectable versus oral GLP-1 formulations This is the section that could prevent a serious mistake
References Cai M, Choi T, Xie Y, Al-Aly Z
Amino Asylum provides detailed information about their products, but users should still exercise caution and consult with professionals before use
Adv Ther 7:2400028 Son J-W, Kim HC, Kim D-H, Ahn J-Y, Park Y-J, Kim J-E (2024) Quality-by-design applied development of tianeptine sodium sustained-release once-a-day dosing tablet
In a number of studies of patients with MDD, evidence has been found of increased neuroinflammatory markers associated with lower levels of antioxidants (Morris et al